Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-16

Clinical Trial Update: Periarticular Penetration of Cefazolin and Clindamycin in Second Stage Revision Arthroplasty of the Hip [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing periarticular penetration of cefazolin and clindamycin in second-stage revision hip arthroplasty for bone and joint infection (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CEFAZOLIN (cefazolin sodium)
  • Clindamycin

Snippet

Sponsor: Radboud University Medical Center | Conditions: PJI, Bone and Joint Infection | Phase 4 | Status: UNKNOWN